Scholarlink

Background <p>Post-induction hypotension is a frequent and clinically significant complication in patients with sepsis undergoing source control surgery, often leading to adverse outcomes such as acute kidney injury. Despite its prevalence, targeted strategies to prevent post-induction hypotension in this population remain underexplored. We aimed to evaluate the efficacy of prophylactic noradrenaline infusion (0.2&#xa0;µg/kg/min) in reducing the incidence of post-induction hypotension in patients with surgical sepsis.</p> Methods <p>In this randomized controlled trial, 80 adult patients with surgical sepsis were allocated to receive either noradrenaline infusion or saline placebo before anesthesia induction. Baseline demographics, laboratory values, and intraoperative parameters were also recorded. The primary outcome was the incidence of postinduction hypotension, defined as a &gt; 20% reduction in mean arterial pressure within 10&#xa0;min of induction. The secondary outcomes included the time to the first hypotensive episode, ephedrine requirements, incidence of acute kidney injury, and other postoperative complications.</p> Results <p>The baseline characteristics were comparable between the groups. The noradrenaline group demonstrated a significantly lower incidence of post-induction hypotension (10% vs. 45%, <i>p</i> &lt; 0.001). Moreover, the incidence of acute kidney injury was markedly lower in the noradrenaline-treated cohort (5%) than in the saline-control group (23%). In contrast, no statistically significant differences were observed between the groups with respect to other clinical outcomes, including myocardial infarction, renal replacement therapy, stroke, and delirium.</p> Conclusion <p>Prophylactic noradrenaline infusion before anesthesia induction significantly improves hemodynamic stability and reduces the risk of acute kidney injury in patients with sepsis undergoing source control surgery. These findings support the use of this technique as a safe and effective strategy for preventing post-induction hypotension in high-risk surgical populations.</p> Trial registration <p>The clinical study was registered on ClinicalTrials.gov by the principal investigator, M. Helmy, under the identifier NCT07022730 on June 7, 2025.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Preemptive noradrenaline infusion: a game-changer against post-induction hypotension in surgical sepsis: a randomized double blind trial

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月11日

查看全文
  • Mina Adolf Helmy,
  • Mohamed Saber Mostafa,
  • Arsany Talaat Saber,
  • Mai A. Ali,
  • Ismail A. Ismail,
  • Beshoy Atef Naguib,
  • Mohamed Maher Elaraby,
  • Lydia Magdy Milad

摘要

Background

Post-induction hypotension is a frequent and clinically significant complication in patients with sepsis undergoing source control surgery, often leading to adverse outcomes such as acute kidney injury. Despite its prevalence, targeted strategies to prevent post-induction hypotension in this population remain underexplored. We aimed to evaluate the efficacy of prophylactic noradrenaline infusion (0.2 µg/kg/min) in reducing the incidence of post-induction hypotension in patients with surgical sepsis.

Methods

In this randomized controlled trial, 80 adult patients with surgical sepsis were allocated to receive either noradrenaline infusion or saline placebo before anesthesia induction. Baseline demographics, laboratory values, and intraoperative parameters were also recorded. The primary outcome was the incidence of postinduction hypotension, defined as a > 20% reduction in mean arterial pressure within 10 min of induction. The secondary outcomes included the time to the first hypotensive episode, ephedrine requirements, incidence of acute kidney injury, and other postoperative complications.

Results

The baseline characteristics were comparable between the groups. The noradrenaline group demonstrated a significantly lower incidence of post-induction hypotension (10% vs. 45%, p < 0.001). Moreover, the incidence of acute kidney injury was markedly lower in the noradrenaline-treated cohort (5%) than in the saline-control group (23%). In contrast, no statistically significant differences were observed between the groups with respect to other clinical outcomes, including myocardial infarction, renal replacement therapy, stroke, and delirium.

Conclusion

Prophylactic noradrenaline infusion before anesthesia induction significantly improves hemodynamic stability and reduces the risk of acute kidney injury in patients with sepsis undergoing source control surgery. These findings support the use of this technique as a safe and effective strategy for preventing post-induction hypotension in high-risk surgical populations.

Trial registration

The clinical study was registered on ClinicalTrials.gov by the principal investigator, M. Helmy, under the identifier NCT07022730 on June 7, 2025.